First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Plexium, Inc.
Plexium, Inc.
Eli Lilly and Company
Rondo Therapeutics
Nuvectis Pharma, Inc.
Novartis
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Carisma Therapeutics Inc
Pfizer
Advaxis, Inc.
Morphotek
AO GENERIUM
Adaptimmune
H. Lee Moffitt Cancer Center and Research Institute
Blueprint Medicines Corporation
Novartis
Checkpoint Therapeutics, Inc.
Novartis
KitovPharma
National Institutes of Health Clinical Center (CC)
University of Rochester
National Institutes of Health Clinical Center (CC)
Santa Maria Biotherapeutics
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
University of Arkansas